Delivery Order SPE2DB22D3301-SPE2DB24FY9JF

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $84K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,246.55 Firm Fixed Price Delivery Order contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,939.22 Firm Fixed Price Delivery Order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The $16,476.49 firm fixed-price delivery order has a completion date of July 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, valued at $16,078.45, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GILENYA 0.5 MG CAPSULE 30S, a specialty medication, with an ultimate completion date of June 26, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $13,659.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of GILENYA 0.5 MG CAPSULE 30S, a prescription medication, to support military healthcare programs. The contract has a firm fixed-price delivery order type and an ultimate completion date of May 16, 2024. The award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,130.03 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of October 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $12,163.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which runs through November 2026. The contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. It has a...
This federal contract award, valued at $78,517.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GILENYA 0.5 MG CAPSULE 30S, a specialty medication. The award is a Delivery Order contract with a Firm Fixed Price pricing type, with a period of performance through May 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,173.78 Firm Fixed Price Delivery Order contract is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of December 22, 2023 and was awarded on December 21, 2023. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed-price delivery order contract valued at $12,076.95 for the supply of GILENYA 0.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00, which serves as Amerisourcebergen Drug Corp's primary contract...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY9JF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $83,960.83 firm fixed-price delivery order is for the supply of GILENYA 0.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of June 27, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely a specific order placed against that larger IDC mechanism. The contract award did not have any set-aside designation, indicating it was open competition.

Generated 5/17/25, 10:09 AM